Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

This study aimed to estimate the between- (HTP) and within- (TP) herd true prevalence distribution of Mycobacterium avium subsp. paratuberculosis (MAP) infection in dairy cattle herds participating in the Danish MAP control programme. All herds enrolled in the programme between 2011 and 2013 were included in the analysis, and one annual milk-ELISA test of all lactating cows present in such herds was considered. A Bayesian latent class model was used to obtain HTP and TP posterior distributions for each year. The model adjusts for uncertainty in age-specific test sensitivity and prior prevalence estimates. Bayesian posterior probabilities were computed in order to compare prevalence between the years. A total of 665,700 samples were included in the study, from 221,914, 224,040, and 220,466 cows sourced from 1138, 1112, and 1059 herds in years 2011, 2012, and 2013, respectively. In that period, HTP estimates of 0.92 (95% posterior probability interval (PPI), 0.87-0.96), 0.78 (95% PPI, 0.74-0.83), and 0.75 (95% PPI, 0.71-0.78) were recorded, respectively. Low TP were observed, with population mean estimates of 0.08 (95% PPI, 0.07-0.08), 0.07 (95% PPI, 0.07-0.08), and 0.07 (95% PPI, 0.06-0.07) for the three consecutive years. Statistically-important differences were recorded for HTP and population mean TP estimates between years, indicating a trend for a decreasing level of MAP infection at both herd and animal level. Model results showed that MAP infection was widespread among the Dairy cattle herds participating in the Danish control programme, though in general it was kept at very low levels.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prevetmed.2015.07.012DOI Listing

Publication Analysis

Top Keywords

95% ppi
20
control programme
12
map infection
12
mycobacterium avium
8
avium subsp
8
subsp paratuberculosis
8
programme herds
8
dairy cattle
8
cattle herds
8
herds participating
8

Similar Publications

Objectives: Proton pump inhibitors (PPIs) are commonly used among these patients to prevent upper gastrointestinal bleeding (UGIB) in anticoagulated patients. However, their clinical benefits among patients receiving OACs with a history of UGIB remain inconclusive. This study aimed to summarize the clinical benefits of PPIs for the secondary prevention of recurrent UGIB among patients using OACs.

View Article and Find Full Text PDF

Network pharmacology and in silico analysis of phytochemicals targeting ER stress in diabetic nephropathy.

In Silico Pharmacol

September 2025

Department of Pharmaceutical Sciences, School of Interdisciplinary and Applied Sciences, Central University of Haryana, Mahendragarh, India.

Abstract: This study aims to identify the molecular mechanism of (CM) in regulating endoplasmic reticulum stress (ER stress) associated with diabetic nephropathy (DN) by using network pharmacology and bioinformatic studies. The targets of CM and target of ER stress and DN were obtained from various online databases. Top targets for CM regulating ER stress in DN were identified using PPI network.

View Article and Find Full Text PDF

Background: A high burden of right ventricular pacing (RVP) increases the risk of hospitalization because of heart failure. Data on predictive factors for high burden of RVP in patients with permanent pacemaker implantation (PPI) after transcatheter aortic valve replacement (TAVR) are limited.

Objective: This study aimed to identify predictors of high RVP burden in patients with current indications for PPI after TAVR.

View Article and Find Full Text PDF

Background: Atopic dermatitis (AD) and ulcerative colitis (UC) are increasingly prevalent, and growing evidence suggests a potential link between them. However, the shared pathogenesis remains unclear. This study aims to identify the hub genes and immunological features underlying the connection between AD and UC.

View Article and Find Full Text PDF

Proton pump inhibitors (PPIs) are among the most commonly prescribed medications in clinical practice. However, emerging evidence has raised concerns about a potential association between PPI use and the risk of myocardial infarction (MI), although the findings remain inconsistent. Given these uncertainties, this study aimed to explore the association between PPI use and the risk of MI in the general population.

View Article and Find Full Text PDF